Adrian V. S. Hill is the Director and Founder of the Jenner Institute and Mittal Professor of Vaccinology at Oxford University. His group has been one of the leaders in the development of adenoviral and other vaccines against infectious diseases and he has tested these in extensively in clinical trials in Africa and Europe. In partnership with the Serum Institute of India and AstraZeneca the Jenner Institute developed rapidly a ChAdOx1 vector-based SARS-CoV-2 vaccine which saved an estimated 6.2 million lives in 2021 alone. His lab has also designed a new malaria vaccine, R21/Matrix-MTM, which has recently reached regulatory reviews for licensure, again in partnership with the Serum Institute of India and also Novavax Inc. In 2021 he was elected a Fellow of the Royal Society and appointed an Honorary Knight Commander of the Order of the British Empire (KBE) in Queen Elizabeth’s Birthday Honours.